相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
Changju Qu et al.
JOURNAL OF IMMUNOTHERAPY (2020)
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer
Andrey A. Gorchakov et al.
EUROPEAN UROLOGY (2020)
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M. Wright et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
Wenjuan Mei et al.
CANCERS (2019)
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Nirav N. Shah et al.
FRONTIERS IN ONCOLOGY (2019)
Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model
Ryo Saga et al.
JOURNAL OF RADIATION RESEARCH (2019)
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L. Smith et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
Chiara Ciardiello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
Il Minn et al.
LANCET ONCOLOGY (2019)
Past, Current, and Future of Immunotherapies for Prostate Cancer
Adeline N. Boettcher et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer stem cells in prostate cancer radioresistance
Tsing Tsao et al.
CANCER LETTERS (2019)
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
Marie-Christine Heinrich et al.
BMC CANCER (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi et al.
CANCER CELL (2018)
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review
Christopher J. D. Wallis et al.
EUROPEAN UROLOGY (2018)
212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape
Carl DeSelm et al.
MOLECULAR THERAPY (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline
Scott C. Morgan et al.
PRACTICAL RADIATION ONCOLOGY (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B. Benzon et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram
Juan Cong et al.
CANCER LETTERS (2017)
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
Juan Ma et al.
ONCOTARGET (2016)
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Zhenling Deng et al.
BMC IMMUNOLOGY (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
John Powderly et al.
Journal for ImmunoTherapy of Cancer (2015)
Cancer Stem Cells in Prostate Cancer Chemoresistance
Jie Ni et al.
CURRENT CANCER DRUG TARGETS (2014)
Blocking the formation of radiation-induced breast cancer stem cells
Yangyang Wang et al.
ONCOTARGET (2014)
Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature
Sanoj Punnen et al.
EUROPEAN UROLOGY (2013)
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
L. Chang et al.
CELL DEATH & DISEASE (2013)
Chk1 knockdown confers radiosensitization in prostate cancer stem cells
Xiaobin Wang et al.
ONCOLOGY REPORTS (2012)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
Grant Chavin et al.
CLINICAL CANCER RESEARCH (2009)
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy
Peter B. Morgan et al.
CANCER (2007)
Natural history of biochemical recurrence after radical prostatectomy: Risk assessment for secondary therapy
Matthew N. Simmons et al.
EUROPEAN UROLOGY (2007)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
WK Suh et al.
NATURE IMMUNOLOGY (2003)
分享论文
